 |
Audiologic and Radiographic Response of NF2-related Vestibular Schwannoma to Erlotinib Therapy CME DisclosuresRelease Date: June 19, 2008; Valid for credit through June 19, 2009 |
| Physicians - maximum of 0.5 AMA PRA Category 1 Credit(s)™ for physicians | |
| Contents of This CME Activity | |
| Legal Disclaimer | |
| The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © 2008 Medscape. |
|
|
|
Learning Objectives Upon completion of this activity, participants will be able to: - List the types of tumors associated with neurofibromatosis type 2 (NF2)
- Describe the birth incidence of NF2
- List the 191 National Institutes of Health (NIH) criteria for the diagnosis of NF2
- Describe the treatment indications and options for NF2
- Identify the potential use of erlotinib in patients with NF2
Authors and Disclosures Scott R. Plotkin, MD, PhD
Disclosure: Scott R. Plotkin, MD, PhD, has disclosed no relevant financial relationships. Marybeth A.
Singh, NP
Disclosure: Marybeth A. Singh, NP, has disclosed no relevant financial relationships. Caroline C. O'Donnell, BA
Disclosure: Caroline C. O'Donnell, BA, has disclosed no relevant financial relationships. Gordon J. Harris, PhD
Disclosure: Gordon J. Harris, PhD, has disclosed no relevant financial
relationships. Andrea I. McClatchey, PhD
Disclosure: Andrea I. McClatchey, PhD, has disclosed no relevant financial relationships. Chris Halpin, PhD
Disclosure: Chris Halpin, PhD, has disclosed no relevant financial relationships. Désirée Lie, MD, MSEd
Disclosure: Désirée Lie, MD, MSEd, has
disclosed no relevant financial relationships. Lisa Hutchinson
Disclosure: Lisa Hutchinson has disclosed no relevant financial relationships. |
 |
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Contact This Provider
|
|
